Calithera Biosciences Cancels Special Meeting Due to Lack of Quorum
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
Special Meeting to be Held on or about June 29, 2023 with a Record Date of May 25, 2023SOUTH SAN FRANCISCO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: CALA) (the "Com
StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)
StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report released on Friday. The firm issued a hold rating on the biotechnology company's stock.Calither
Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report released on Friday morning. The brokerage issued a hold rating on the biotechnology company's
StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)
Equities researchers at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage se
Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com
Analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report released on Monday. The firm set a "hold" rating on the biotechnology company's s
Comparing Calithera Biosciences (NASDAQ:CALA) & ScPharmaceuticals (NASDAQ:SCPH)
scPharmaceuticals (NASDAQ:SCPH – Get Rating) and Calithera Biosciences (NASDAQ:CALA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two bus
Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the biotechnolo
Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research report sent to investors on Friday. The firm issued a hold rating on the biotechnology company'
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and
Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating From Analysts at StockNews.com
StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotech
Calithera Biosciences, Inc. (NASDAQ:CALA) Short Interest Down 12.1% in January
Calithera Biosciences, Inc. (NASDAQ:CALA – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 366,600 shares, a d
Deepika Pakianathan Sells 121,333 Shares of Calithera Biosciences, Inc. (NASDAQ:CALA) Stock
Calithera Biosciences, Inc. (NASDAQ:CALA – Get Rating) Director Deepika Pakianathan sold 121,333 shares of the firm's stock in a transaction dated Friday, January 27th. The shares were sold at an ave
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersBright Green (NASDAQ:BGXX) shares increased by 251.2% to $1.83 during Wednesday's regular session. The current volume of 81.8 million shares is 25935.4% of Bright Green's average full-day volum
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNymox Pharmaceutical (NASDAQ:NYMX) shares rose 21.8% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $45.2 million. Brainstorm Cell (NASDAQ:BCLI
Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com
Stock analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research note issued on Monday. The brokerage set a "hold" rating on the biotechnolog
12 Health Care Stocks Moving In Friday's After-Market Session
GainersVaccitech (NASDAQ:VACC) shares rose 8.5% to $3.2 during Friday's after-market session. The company's market cap stands at $119.3 million. Calithera Biosciences (NASDAQ:CALA) shares rose 7.34% t
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersGT Biopharma (NASDAQ:GTBP) shares increased by 7.4% to $0.91 during Wednesday's after-market session. The market value of their outstanding shares is at $33.0 million. Science 37 Hldgs (NASDAQ:
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 80.0% to $2.16 during Wednesday's pre-market session. The company's market cap stands at $6.7 million. First Wave BioPharma (NASDAQ:FWBI) stock m
No Data